Skip to main content
. Author manuscript; available in PMC: 2007 Jun 30.
Published in final edited form as: Auton Neurosci. 2006 May 2;126-127:380–389. doi: 10.1016/j.autneu.2006.02.030

Figure 1.

Figure 1

Semi-quantitative analysis of fractalkine or fractalkine receptor-immunoreactivity (IR) in the urothelium after CYP-induced cystitis. Grayscale versions of fractalkine-IR in control urinary bladder (A) or after 48 hr CYP-treatment (B) with the urothelium (u) outlined in green are demonstrated. Both images are thresholded and little fractalkine (absence of green within the outlined region) is above threshold in control compared to significant fractalkine-IR that is above threshold after 48 hr CYP treatment (B, presence of green within the u). Calibration bar represents 50 μm.